LAWSUIT AGAINST IMPAX DRUG DISMISSED

Impax Laboratories Inc. said Tuesday that a lawsuit over a generic drug for attention deficit disorder was dismissed. Alza Corp. and McNeil Consumer & Specialty Pharmaceuticals filed the suit last year in U.S. District Court in Delaware over Impax's application with the Food and Drug Administration for a generic form of Concerta. McNeil -- a division of Johnson & Johnson -- sells Concerta as a treatment for attention deficit disorder and hyperactivity disorder.

San Francisco Business Times (http://sanfrancisco.bizjournals.com/sanfrancisco/stories/2006/10/02/daily16.html)